Histone deacetylase inhibitors

Details for Australian Patent Application No. 2005280211 (hide)

International Classifications

Event Publications

15 March 2007 PCT application entered the National Phase

PCT publication WO2006/026260 Priority application(s): WO2006/026260

21 June 2007 Change of Name(s) of Applicant(s), Section 104

Merck & Co., Inc.; Aton Pharma, Inc. The name of the applicant has been changed to Merck & Co., Inc.

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.